Nine months after closing a $450…
Nine months after closing a $450 million fundraise, Atlas Venture [...]
AC Immune is reducing its…
AC Immune is reducing its workforce by around 30% and [...]
Enveda has closed its second $150…
Enveda has closed its second $150 million financing round of [...]
Texas Senate Passes Bill to Crack Down on Mail-Order Abortion Pills
Gov. Greg Abbott is expected to sign the legislation, which [...]
A phase 3 trial of Sanofi’s…
A phase 3 trial of Sanofi’s eczema prospect amlitelimab has [...]
F.D.A. Official Overruled Scientists on Wide Access to Covid Shots
The agency’s staff scientists pointed out how Covid was still [...]
An interim analysis reported in…
An interim analysis reported in June showed that Amgen’s Zai [...]
Gilead Sciences’ Kite Pharma has…
Gilead Sciences’ Kite Pharma has cut off a collaboration with [...]
A new awareness-raising effort…
A new awareness-raising effort from Incyte is aimed at giving [...]
After becoming the first group to…
After becoming the first group to therapeutically edit human RNA [...]